-
1
-
-
0025300052
-
Diversity of Conus neuropeptides
-
Olivera B.M., Rivier J.E., Clark C., Ramilo C.A., Corpuz G.P., Abogadie F.C., Mena E., Woodward S.R., Hillyard D.R., and Cruz L.J. Diversity of Conus neuropeptides. Science 249 (1990) 257-263
-
(1990)
Science
, vol.249
, pp. 257-263
-
-
Olivera, B.M.1
Rivier, J.E.2
Clark, C.3
Ramilo, C.A.4
Corpuz, G.P.5
Abogadie, F.C.6
Mena, E.7
Woodward, S.R.8
Hillyard, D.R.9
Cruz, L.J.10
-
2
-
-
0003042767
-
-
Rochat H., and Martin-Eauclaire (Eds), Birkhauser Verlag, Basel
-
Cruz L.J., McIntosh J.M., Imperial J.S., and Gray W. In: Rochat H., and Martin-Eauclaire (Eds). Methods and Tools in Biosciences and Medicine (2000), Birkhauser Verlag, Basel 74-89
-
(2000)
Methods and Tools in Biosciences and Medicine
, pp. 74-89
-
-
Cruz, L.J.1
McIntosh, J.M.2
Imperial, J.S.3
Gray, W.4
-
3
-
-
9144272640
-
Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain
-
Miljanich G.P. Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem. 11 (2004)
-
(2004)
Curr. Med. Chem.
, vol.11
-
-
Miljanich, G.P.1
-
4
-
-
3042631514
-
Drugs from the sea: Conopeptides as potential therapeutics
-
Livett B.G., Gayler K.R., and Khalil Z. Drugs from the sea: Conopeptides as potential therapeutics. Curr. Med. Chem. 11 (2004) 1715-1723
-
(2004)
Curr. Med. Chem.
, vol.11
, pp. 1715-1723
-
-
Livett, B.G.1
Gayler, K.R.2
Khalil, Z.3
-
5
-
-
0025160022
-
Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites
-
Ward J.M., Crockcroft V.B., Lunt G.G., Smillie F.S., and Wonnacott S. Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett. 270 (1990) 45-48
-
(1990)
FEBS Lett.
, vol.270
, pp. 45-48
-
-
Ward, J.M.1
Crockcroft, V.B.2
Lunt, G.G.3
Smillie, F.S.4
Wonnacott, S.5
-
6
-
-
0027518923
-
Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium
-
Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13 (1993) 596-604
-
(1993)
J. Neurosci.
, vol.13
, pp. 596-604
-
-
Seguela, P.1
Wadiche, J.2
Dineley-Miller, K.3
Dani, J.A.4
Patrick, J.W.5
-
7
-
-
0025472462
-
Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations
-
Luetje C.W., Wanda K., Rogers S., Abramson S.N., Tsuji K., Heinemann S., and Patrick J.W. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem. 55 (1990) 632-640
-
(1990)
J. Neurochem.
, vol.55
, pp. 632-640
-
-
Luetje, C.W.1
Wanda, K.2
Rogers, S.3
Abramson, S.N.4
Tsuji, K.5
Heinemann, S.6
Patrick, J.W.7
-
8
-
-
0032881372
-
Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes
-
McIntosh J.M., Santos A.D., and Olivera B.M. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Ann. Rev. Biochem. 68 (1999) 59-88
-
(1999)
Ann. Rev. Biochem.
, vol.68
, pp. 59-88
-
-
McIntosh, J.M.1
Santos, A.D.2
Olivera, B.M.3
-
9
-
-
18744413004
-
a-Conotoxins as selective probes for nicotinic acetylchholine receptor subclasses
-
Janes R.W. a-Conotoxins as selective probes for nicotinic acetylchholine receptor subclasses. Curr. Opin. .Pharmacol. 5 (2005) 280-292
-
(2005)
Curr. Opin. .Pharmacol.
, vol.5
, pp. 280-292
-
-
Janes, R.W.1
-
10
-
-
33750957742
-
Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor
-
Livett B.G., Sandall D.W., Keays D., Down J., Gayler K.R., Satkunanathan N., and Khalil Z. Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon 48 (2006) 810-829
-
(2006)
Toxicon
, vol.48
, pp. 810-829
-
-
Livett, B.G.1
Sandall, D.W.2
Keays, D.3
Down, J.4
Gayler, K.R.5
Satkunanathan, N.6
Khalil, Z.7
-
11
-
-
25444448796
-
Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the α-conotoxin MII
-
Clark R., Fischer J.H., Dempster L., Daly N.L., Rosengren K.J., Nevin S.T., Meunier F.A., Adams D.J., and Craik D.J. Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the α-conotoxin MII. PNAS 102 (2005) 13767-13772
-
(2005)
PNAS
, vol.102
, pp. 13767-13772
-
-
Clark, R.1
Fischer, J.H.2
Dempster, L.3
Daly, N.L.4
Rosengren, K.J.5
Nevin, S.T.6
Meunier, F.A.7
Adams, D.J.8
Craik, D.J.9
-
12
-
-
0344406263
-
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII
-
Blanchfield J., Dutton J., Hogg R., Gallagher O., Craik D., Jones A., Adams D., Lewis R., Alewood P., and Toth I. Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J. Med. Chem. 46 (2003) 1266-1272
-
(2003)
J. Med. Chem.
, vol.46
, pp. 1266-1272
-
-
Blanchfield, J.1
Dutton, J.2
Hogg, R.3
Gallagher, O.4
Craik, D.5
Jones, A.6
Adams, D.7
Lewis, R.8
Alewood, P.9
Toth, I.10
-
13
-
-
0029871748
-
A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors
-
Cartier E.G., Yoshikami D., Gray W., Luo R.S., Olivera B.M., and McIntosh J.M. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J. Biol. Chem. 271 (1996) 7522-7528
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 7522-7528
-
-
Cartier, E.G.1
Yoshikami, D.2
Gray, W.3
Luo, R.S.4
Olivera, B.M.5
McIntosh, J.M.6
-
14
-
-
0031469571
-
Three-dimensional solution structure of α-conotoxin MII, an α3β2 neuronal nicotinic acetylcholine receptor-targeted ligand
-
Shon K.-J., Koerber S.C., Rivier J.E., Olivera B.M., and McIntosh J.M. Three-dimensional solution structure of α-conotoxin MII, an α3β2 neuronal nicotinic acetylcholine receptor-targeted ligand. Biochem. 36 (1997) 15693-15700
-
(1997)
Biochem.
, vol.36
, pp. 15693-15700
-
-
Shon, K.-J.1
Koerber, S.C.2
Rivier, J.E.3
Olivera, B.M.4
McIntosh, J.M.5
-
15
-
-
0032506167
-
Three-dimensional solution structure of α-conotoxin MII by NMR spectroscopy: Effects of solution environment on helicity
-
Hill J.M., Oomen C.J., Miranda L.P., Bingham J.-P., Alewood P.F., and Craik D.J. Three-dimensional solution structure of α-conotoxin MII by NMR spectroscopy: Effects of solution environment on helicity. Biochem. 37 (1998) 15621-15630
-
(1998)
Biochem.
, vol.37
, pp. 15621-15630
-
-
Hill, J.M.1
Oomen, C.J.2
Miranda, L.P.3
Bingham, J.-P.4
Alewood, P.F.5
Craik, D.J.6
-
16
-
-
4444244953
-
Lipid, sugar and liposaccharide based delivery systems 2
-
Blanchfield J.T., and Toth I. Lipid, sugar and liposaccharide based delivery systems 2. Curr. Med. Chem. 11 (2004) 2375-2382
-
(2004)
Curr. Med. Chem.
, vol.11
, pp. 2375-2382
-
-
Blanchfield, J.T.1
Toth, I.2
-
17
-
-
0019480198
-
Prodrugs as drug delivery systems
-
Bundgaard H., and Hansen B.B. Prodrugs as drug delivery systems. Pharmacy Int. (1981) 136-140
-
(1981)
Pharmacy Int.
, pp. 136-140
-
-
Bundgaard, H.1
Hansen, B.B.2
-
18
-
-
33846230530
-
Plasma protein binding affinity and its relationship to molecualr structure: An in-silico analysis
-
Gleeson P.M. Plasma protein binding affinity and its relationship to molecualr structure: An in-silico analysis. J. Med. Chem. 50 (2007) 101-112
-
(2007)
J. Med. Chem.
, vol.50
, pp. 101-112
-
-
Gleeson, P.M.1
-
19
-
-
34547104709
-
The correlation of serum protein association and cellular uptake with lipophilicity and polarity of the backbone substituent of the technitium-99m-amine-oxime chelates
-
Li L., Xu Y., and Su Z. The correlation of serum protein association and cellular uptake with lipophilicity and polarity of the backbone substituent of the technitium-99m-amine-oxime chelates. J. Label. Comp. Radiopharm. 50 (2007) 91-95
-
(2007)
J. Label. Comp. Radiopharm.
, vol.50
, pp. 91-95
-
-
Li, L.1
Xu, Y.2
Su, Z.3
-
20
-
-
33644788804
-
CNS drug delivery: opioid peptides and the blood-brain barrier
-
Witt K.A., and Davis T.P. CNS drug delivery: opioid peptides and the blood-brain barrier. AAPS Journal 8 (2006) E76-E88
-
(2006)
AAPS Journal
, vol.8
-
-
Witt, K.A.1
Davis, T.P.2
-
21
-
-
0034013024
-
Bioavailablity of Ziconotide in brain: influx from blood, stability and diffusion
-
Newcomb R., Abbruscata T.J., Singh T., Nadaski L., Davis T.P., and Miljanich G. Bioavailablity of Ziconotide in brain: influx from blood, stability and diffusion. Peptides 21 (2000) 491-501
-
(2000)
Peptides
, vol.21
, pp. 491-501
-
-
Newcomb, R.1
Abbruscata, T.J.2
Singh, T.3
Nadaski, L.4
Davis, T.P.5
Miljanich, G.6
-
23
-
-
0027310350
-
SDZCO611: A highly potent glycated analog of somatostatin with improved oral activity
-
Albert R., Marbach P., Bauer W., Briner U., Fricker G., Bruns C., and Pless J. SDZCO611: A highly potent glycated analog of somatostatin with improved oral activity. Life Sciences 53 (1993)
-
(1993)
Life Sciences
, vol.53
-
-
Albert, R.1
Marbach, P.2
Bauer, W.3
Briner, U.4
Fricker, G.5
Bruns, C.6
Pless, J.7
-
24
-
-
0028009171
-
Effect of a new oral somatostatin analog (SDZCO611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects
-
Nelson-Piercy C., Hammond P.J., Gwilliam M.E., Khandan-Nia N., Myers M.J., Ghatei M.A., and Bloom S.R. Effect of a new oral somatostatin analog (SDZCO611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. J. Clin. Endocrin. Metab. 78 (1994) 329-336
-
(1994)
J. Clin. Endocrin. Metab.
, vol.78
, pp. 329-336
-
-
Nelson-Piercy, C.1
Hammond, P.J.2
Gwilliam, M.E.3
Khandan-Nia, N.4
Myers, M.J.5
Ghatei, M.A.6
Bloom, S.R.7
-
25
-
-
0347316399
-
Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: Results from a Phase I/II clinical trial
-
Clement S., Dandona P., Still G.J., and Kosutic G. Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: Results from a Phase I/II clinical trial. Metabolism 53 (2004) 54-58
-
(2004)
Metabolism
, vol.53
, pp. 54-58
-
-
Clement, S.1
Dandona, P.2
Still, G.J.3
Kosutic, G.4
-
26
-
-
0036105205
-
Development of oral insulin: progress and current status
-
Still G.J. Development of oral insulin: progress and current status. Diabetes Metab. Res. Rev. 18 (2002) S29-S37
-
(2002)
Diabetes Metab. Res. Rev.
, vol.18
-
-
Still, G.J.1
-
27
-
-
0030596514
-
Oral absorption studies of lipidic conjugates of thyrotropin releasing hormone (TRH) and luteinizing hormone-releasing hormone (LHRH)
-
Flinn N., Coppard S., and Toth I. Oral absorption studies of lipidic conjugates of thyrotropin releasing hormone (TRH) and luteinizing hormone-releasing hormone (LHRH). Inter. J. Pharm. (1996) 33-39
-
(1996)
Inter. J. Pharm.
, pp. 33-39
-
-
Flinn, N.1
Coppard, S.2
Toth, I.3
-
28
-
-
33745083089
-
Reversible lipidization for the oral delivery of leu-enkephalin
-
Wang J., Hogenkamp D.J., Tran M., Li W.-Y., Yoshimura R.F., Johnstone T.B.C., Shen W.-C., and Gee K.W. Reversible lipidization for the oral delivery of leu-enkephalin. J. Drug Target. 14 (2006) 127-136
-
(2006)
J. Drug Target.
, vol.14
, pp. 127-136
-
-
Wang, J.1
Hogenkamp, D.J.2
Tran, M.3
Li, W.-Y.4
Yoshimura, R.F.5
Johnstone, T.B.C.6
Shen, W.-C.7
Gee, K.W.8
-
29
-
-
0037467203
-
Reversible lipidization for the oral delivery of salmon calcitonin
-
Wang J., Chow D., Heiati H., and Shen W.-C. Reversible lipidization for the oral delivery of salmon calcitonin. J. Controll. Rel. 88 (2003) 369-380
-
(2003)
J. Controll. Rel.
, vol.88
, pp. 369-380
-
-
Wang, J.1
Chow, D.2
Heiati, H.3
Shen, W.-C.4
-
30
-
-
0032709221
-
Preparation, Purification and Characterization of a reversibaly lipidized desmopressin with potentiated anti-diuretic activity
-
Wang J., Shen D., and Shen W.-C. Preparation, Purification and Characterization of a reversibaly lipidized desmopressin with potentiated anti-diuretic activity. Pharma. Res. 16 (1999) 1674-1679
-
(1999)
Pharma. Res.
, vol.16
, pp. 1674-1679
-
-
Wang, J.1
Shen, D.2
Shen, W.-C.3
-
32
-
-
0026486811
-
In situ neutralization in Boc-chemistry solid phase peptide synthesis
-
Schnolzer M., Alewood P.F., Jones A., Alewood D., and Kent S.B.H. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Inter. J. Pep. Pro. Res. 40 (1992) 180-193
-
(1992)
Inter. J. Pep. Pro. Res.
, vol.40
, pp. 180-193
-
-
Schnolzer, M.1
Alewood, P.F.2
Jones, A.3
Alewood, D.4
Kent, S.B.H.5
|